Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)

10
End-of-day quote. End-of-day quote Copenhagen Stock Exchange - 01/29
1.66 DKK   0.00%
01/28 BIOPORTO A/S : Market rumours about rejection of NGAL cut-off patent..
01/06 BIOPORTO A/S : New CFO at BioPorto A/S.
2014 BIOPORTO A/S : Financial Calender 2015
 SummaryChart AnalysisNewsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
01/23/2015 01/26/2015 01/27/2015 01/28/2015 01/29/2015 Date
1.79 1.74 1.72 1.66 1.66 Last
680384 611036 390136 1833210 229594 Volume
-1.10% -2.79% -1.15% -3.49% 0.00% Change
Company
BioPorto A/S engages in the manufacture and distribution of antibodies and antibody-based products.It also offers tests to diagnose human disease for individual patients and to the health sector.The company operates through the following segments: Human Diagnostics, Other Kits & Reagents, Licenses... 
Sector
Pharmaceuticals
Calendar
03/18Earnings Release
More about the company
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Full-screen chart
Latest news on BIOPORTO A/S
01/28 BIOPORTO A/S : Market rumours about rejection of NGAL cut-off patent application
01/06 BIOPORTO A/S : New CFO at BioPorto A/S.
2014 BIOPORTO A/S : Financial Calender 2015
2014 BIOPORTO A/S : Interim Financial Report for Q3 2014 for the BioPorto Group
2014 BIOPORTO A/S : Frost & Sullivan awards Product Leadership Award to BioPorto Diag..
2014 BIOPORTO A/S : Interim Financial Report for the first half of 2014 for the BioPo..
2014 BIOPORTO A/S : maintains its assessment of the IP situation regarding NGAL and c..
2014 BIOPORTO A/S : Interim Financial Report for Q1 2014 for the BioPorto Group
More news
Sector news Diagnostic & Testing Substances Manufacturers
01:35p Business events scheduled for Friday
01:07p ABBOTT LABORATORIES : Mylan says shareholders approve Abbott business purchase
01:05p ALEXION PHARMACEUTICALS : Names New CEO
Plus d'actualités du secteur Diagnostic & Testing Substances Manufacturers


Comments 
Advertisement
Dynamic quotes  
ON
| OFF